Article
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey.
Journal of clinical pathology - 1 May 2021
Akgul Mahmut, Williamson Sean R, Ertoy Dilek, Argani Pedram, Gupta Sounak, Caliò Anna, Reuter Victor, Tickoo Satish, Al-Ahmadie Hikmat A, Netto George J, Hes Ondrej, Hirsch Michelle S, Delahunt Brett, Mehra Rohit, Skala Stephanie, Osunkoya Adeboye O, Harik Lara, Rao Priya, Sangoi Ankur R, Nourieh Maya, Zynger Debra L, Smith Steven Cristopher, Nazeer Tipu, Gumuskaya Berrak, Kulac Ibrahim, Khani Francesca, Tretiakova Maria S, Vakar-Lopez Funda, Barkan Guliz, Molinié Vincent, Verkarre Virginie, Rao Qiu, Kis Lorand, Panizo Angel, Farzaneh Ted, Magers Martin J, Sanfrancesco Joseph, Perrino Carmen, Gondim Dibson, Araneta Ronald, So Jeffrey S, Ro Jae Y, Wasco Matthew, Hameed Omar, Lopez-Beltran Antonio, Samaratunga Hemamali, Wobker Sara E, Melamed Jonathan, Cheng Liang, Idrees Muhammad T
Abstract excerpt
Transcription factor E3-rearranged renal cell carcinoma (TFE3-RCC) has heterogenous morphologic and immunohistochemical (IHC) features.131 pathologists with genitourinary expertise were invited in an online survey containing 23 questions assessing their experience on TFE3-RCC diagnostic work-up.Fifty (38%) participants completed the survey. 46 of 50 participants reported multiple patterns, most commonly papillary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.